Oslo University Hospital: clinical-trial pipeline
Oslo University Hospital is the sponsor of 830 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 196 are not yet finished and 5 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 615 |
| Phase 2 | 68 |
| Phase 4 | 66 |
| Phase 3 | 28 |
| Phase 1/2 | 23 |
| Phase 2/3 | 14 |
| Phase 1 | 10 |
| Early phase 1 | 6 |
Trials by status
| Status | Trials |
|---|---|
| Completed | 437 |
| Unknown | 150 |
| Recruiting | 115 |
| Active, not recruiting | 68 |
| Terminated | 37 |
| Not yet recruiting | 13 |
| Withdrawn or not authorised | 7 |
| Suspended or halted | 3 |
Condition areas
| Area | Trials |
|---|---|
| Oncology | 166 |
| Cardiovascular | 151 |
| Immunology and rheumatology | 65 |
| Neurology | 62 |
| Musculoskeletal | 58 |
| Gastroenterology and liver | 55 |
| Nephrology and urology | 55 |
| Rare and genetic diseases | 53 |
| Metabolic and endocrine (diabetes, obesity) | 47 |
| Psychiatry and mental health | 42 |
| Women's health and obstetrics | 42 |
| Infectious disease and vaccines | 40 |
Countries
| Country | Trials |
|---|---|
| Norway | 765 |
| Sweden | 19 |
| Denmark | 14 |
| Finland | 9 |
| Netherlands | 6 |
| Belgium | 5 |
| Germany | 5 |
| Italy | 5 |
| United Kingdom | 4 |
| Lithuania | 4 |
| United States | 4 |
| Australia | 3 |
| Czechia | 3 |
| Ethiopia | 3 |
| France | 3 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-10-13 | New trial posted | Infarct Growth After Intravenous Tocilizumab in Adults With Acute Ischemic Stroke Undergo… |
| 2026-10-09 | New trial posted | Trabeculectomy Versus MicroShunt Implantation in Glaucoma Surgery (TIGER) |
| 2026-09-29 | New trial posted | Quadratus Lumborum Block for Iliac Bone Harvest in Pediatric Cleft Alveolus Repair |
| 2026-09-25 | New trial posted | Exercise and Tissue-Specific Insulin Sensitivity in South Asian and Nordic Women With Pre… |
| 2026-09-21 | New trial posted | Mitral Valve Prolapse Arrhythmic Risk |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT06651151 | NeoLIPA: Neoadjuvant LTX-315 in Combination with Pembrolizumab in Resectable Stage III/IV Melanoma | Phase 2 | Recruiting | Norway |
| NCT05725200 | Study to Investigate Outcome of Individualized Treatment in Patients With Metastatic Colorectal Cancer | Phase 2 | Recruiting | Norway |
| NCT04207177 | Immunosuppressive Drugs and Gut Microbiome: Pharmacokinetic- and Microbiome Diversity Effects | Phase 4 | Recruiting | Norway |
| NCT05788276 | Can Dapagliflozin Preserve Structure and Function in Transplanted Kidneys? | Phase 4 | Active, not recruiting | Norway |
| NCT06729034 | A Study of Direct Oral Anticoagulants in Patients with Painful Venous Malformations with Localized Intravascu… | Phase 2 | Recruiting | Norway |
| NCT04817956 | Improving Public Cancer Care by Implementing Precision Medicine in Norway | Phase 2 | Recruiting | Norway |
| NCT06653634 | Optimizing Treatment for Patients With Juvenile Idiopathic Arthritis in Sustained Remission: The MOVE-JIA Tri… | Phase 4 | Recruiting | Norway |
| NCT05029050 | Dexmedetomidine or Clonidine Infusion for Prevention of Delirium After Open Heart Surgery | Phase 4 | Active, not recruiting | Norway |
| NCT04513639 | The Relapse from MRD Negativity As Indication for Treatment (REMNANT) Study | Phase 2/3 | Active, not recruiting | Lithuania, Norway |
| NCT03544736 | Safety and Feasibility of Irradiation and Nivolumab in Esophageal Cancer (INEC) | Phase 1/2 | Active, not recruiting | Norway |
| NCT05719467 | SAINT: Safe Induction of Labor Trial | Phase 3 | Active, not recruiting | Norway |
| NCT04939844 | REST - Replacing Steroids in the Transplant Ineligble | Phase 2 | Active, not recruiting | Denmark, Norway |
| NCT05043701 | Individualized Systems Medicine Functional Profiling for Recurrent Glioblastoma | Early phase 1 | Recruiting | Norway |
| NCT03548571 | Dendritic Cell Immunotherapy Against Cancer Stem Cells in Glioblastoma Patients Receiving Standard Therapy | Phase 2/3 | Recruiting | Norway |
| NCT02919787 | Nordic Pancreatic Cancer Trial (NorPACT) - 1 | Phase 2/3 | Active, not recruiting | Denmark, Finland, Norway, Sweden |
| NCT05056389 | Normothermic Intraperitoneal Chemotherapy - Long Term in Peritoneal Metastases From Colorectal Cancer (NIPEC-… | Phase 1 | Recruiting | Norway |
| NCT05578586 | A Pilot Study for Optimizing Meropenem Administration in the ICU | Not applicable | Recruiting | Norway |
| NCT06119789 | Precision Cancer Therapy in Rare Cancers | Phase 2 | Recruiting | Norway |
| NCT07341360 | Pseudovax - A Cancer Vaccine for Patients With Pseudomyxoma Peritonei | Early phase 1 | Recruiting | Norway |
| NCT03646357 | BEtablocker Treatment After Acute Myocardial Infarction in Patients Without Reduced Left Ventricular Systolic… | Phase 4 | Active, not recruiting | Norway |
| NCT05841550 | The TG01 Study With TG01/QS-21 Vaccine in Patients With High-risk Smouldering Multiple Myeloma and Multiple M… | Phase 1/2 | Recruiting | Norway |
| NCT06788314 | A Study of Enalapril in Treatment of Venous Malformations | Phase 2 | Recruiting | Norway |
| NCT04993131 | Liver Transplantation for Non-resectable Perihilar Cholangiocarcinoma | Not applicable | Recruiting | Norway |
| NCT05399446 | Multi-Site Eating Disorder Prevention Program for Type 1 Diabetes | Not applicable | Active, not recruiting | Netherlands, Norway, United States |
| NCT04957628 | AlcoTail - Implementation of Tailored Interventions | Not applicable | Recruiting | Norway |
All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "Oslo University Hospital clinical trials: 196 open, 42 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/oslo-university-hospital/, data as of 2026-10-25.